You are here

Article Text

Article menu

Download PDFPDF

Recommendation
2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
  1. Désirée van der Heijde1,
  2. Daniel Aletaha2,
  3. Loreto Carmona3,
  4. Christopher J Edwards4,5,
  5. Tore K Kvien6,
  6. Marios Kouloumas7,
  7. Pedro Machado1,8,
  8. Sue Oliver9,
  9. Maarten de Wit7,
  10. Maxime Dougados10,11
  1. 1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  2. 2Division of Rheumatology, Medical University of Vienna, Vienna, Austria
  3. 3Institute of Musculoskeletal Health, Madrid, Spain
  4. 4NIHR Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, UK
  5. 5Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
  6. 6Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  7. 7EULAR Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), Zurich, Switzerland
  8. 8Coimbra University Hospital, Coimbra, Portugal
  9. 9Independent Nurse Consultant, North Devon, UK
  10. 10Rheumatology Department, Paris Descartes University, Cochin Hospital, Paris, France
  11. 11INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France
  1. Correspondence to Professor Désirée van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; mail{at}dvanderheijde.nl

Abstract

In this article, the European League Against Rheumatism (EULAR) standardised operating procedures for the elaboration, evaluation, dissemination and implementation of recommendations endorsed by the EULAR standing committees published in 2004 have been updated. The various steps from the application to implementation have been described in detail.

  • Epidemiology
  • Qualitative research
  • Outcomes research

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

View Full Text

http://dx.doi.org/10.1136/annrheumdis-2014-206350

Statistics from Altmetric.com

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/